U.S. Food Stock News

Forgent Power Solutions, Inc. recently completed an upsized follow-on equity offering of 42,280,000 Class A common shares at US$47.00 each, raising about US$1.99 billion, while also repricing its credit facilities to lower interest costs. Although Forgent will not retain the equity proceeds directly, the transaction broadens its public float and coincides with interest savings from reduced loan margins on its senior credit facilities. We’ll now consider how the large equity raise and...

Wondering whether Waste Management at around US$211.46 per share offers fair value or a possible opportunity? This article focuses squarely on what the current price could mean for you. The stock has pulled back recently, with returns declining 3.0% over the past week, 7.6% over the past month, and 3.2% year to date. The 1 year return is down 10.9%, set against a 3 year gain of 33.6% and a 5 year gain of 61.8%. Recent headlines have centered on Waste Management as a major US waste services...

Agios Pharmaceuticals halted development of tebapivat in lower risk myelodysplastic syndromes after a Phase 2b trial did not meet internal efficacy thresholds. The decision removes a candidate from Agios’s rare blood disorder pipeline and follows a review of trial data against the company’s internal benchmarks. Agios plans to continue concentrating resources on its sickle cell disease program and broader portfolio in rare hematologic conditions. For investors tracking NasdaqGS:AGIO, the...

GameStop (NYSE:GME) is pushing ahead with an attempt to acquire eBay after its offer was rejected. The company has publicly proposed leading the combined business as CEO if a deal goes ahead. Following eBay's rejection, GameStop increased its stake in the online marketplace as part of an ongoing takeover effort. GameStop, best known for its video game retail business, has been working to reposition itself toward digital and online commerce. eBay operates a large global marketplace that...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Anyone interested in Turtle Beach Corporation ( NASDAQ:TBCH ) should probably be aware that the Independent Director...

We'd be surprised if Sierra Bancorp ( NASDAQ:BSRR ) shareholders haven't noticed that the Executive VP & Chief Credit...

Eli Lilly recently reported extensive Phase 3 data for its obesity and diabetes pipeline at the American Diabetes Association meeting, highlighted by retatrutide’s triple-agonist profile and Foundayo’s performance versus existing oral therapies, alongside earlier positive base-editing results for VERVE-102 in high-risk cholesterol patients. At the same time, all three largest US pharmacy benefit managers have agreed to cover Lilly’s full obesity portfolio, materially broadening access to...

Costco Wholesale (COST) is back in focus after reporting fiscal third quarter results that topped revenue and earnings expectations, helped by record gasoline volumes, stronger e-commerce activity, and higher membership fee income. See our latest analysis for Costco Wholesale. Despite the strong Q3 report, Costco’s share price has recently come under pressure, with a 1 day share price return of down 3.9% and a 7 day share price return of down 7%. At the same time, the year to date share price...

Pagaya Technologies recently named Terry O’Neil as Chief Commercial Officer to lead partnerships and growth, while also closing its largest-ever US$600 million auto asset-backed securitization and pursuing legal action against Klarna over alleged misappropriation of its credit decisioning technology. These developments, combined with five consecutive GAAP-profitable quarters and raised earnings guidance, highlight how Pagaya is expanding its AI-powered lending infrastructure while seeking to...

Record results and AI demand put Teradyne (TER) in focus Recent commentary on Teradyne (TER) highlights record revenues and earnings, along with growing AI and robotics demand, putting the stock on many investors’ radar and raising questions about how sustainable this business momentum may be. See our latest analysis for Teradyne. Teradyne’s share price has been strong over multiple timeframes, with a 7 day share price return of 4.43%, a 90 day share price return of 14.88% and an 80.34% year...

Lumen Technologies (NYSE:LUMN) announced the acquisition of Alkira, a cloud-native networking platform provider. The transaction is intended to accelerate Lumen's digital platform strategy and expand its cloud and networking capabilities. The deal marks a shift in focus toward growth initiatives beyond Lumen's legacy telecom services. Lumen Technologies operates as a communications and digital infrastructure company, and this move directs more of its focus toward cloud networking and...

PodcastOne, Inc. ( NASDAQ:PODC ) is possibly approaching a major achievement in its business, so we would like to shine...

Nordic American Tankers Limited ( NYSE:NAT ) shareholders will have a reason to smile today, with the analysts making...

It looks like Cass Information Systems, Inc. ( NASDAQ:CASS ) is about to go ex-dividend in the next 4 days. The...

Anyone interested in USANA Health Sciences, Inc. ( NYSE:USNA ) should probably be aware that the Chief People Officer...

Some Huntington Ingalls Industries, Inc. ( NYSE:HII ) shareholders may be a little concerned to see that insider Edmond...

We wouldn't blame Monarch Casino & Resort, Inc. ( NASDAQ:MCRI ) shareholders if they were a little worried about the...

MSCI (MSCI) has drawn fresh attention after analyst upgrades highlighted its role in data driven and AI enabled financial tools, following quarterly results that featured record recurring sales across its index and analytics businesses. See our latest analysis for MSCI. Recent upgrades and the April results have coincided with firm momentum in the stock, with a 30 day share price return of 7.22% and a 5 year total shareholder return of 43.09%, suggesting interest has been building over...

At its May 28, 2026 annual meeting, Ondas Inc. approved an increase in authorized common shares to 1.20 billion and filed new shelf registrations totaling about US$258.45 million for potential common stock issuance, including an ESOP-related offering. These moves give Ondas more flexibility to fund growth initiatives such as expanding defense and autonomous systems production while supporting employee ownership through equity plans. With Ondas securing over US$110 million in second-quarter...

PulteGroup stock snapshot after recent performance PulteGroup (PHM) has delivered mixed recent returns, with the stock edging up over the past week but down over the past month and past 3 months, leaving some investors reassessing the homebuilder’s current pricing. See our latest analysis for PulteGroup. At a share price of $118.18, PulteGroup’s short term share price performance has softened. However, its 1 year and multi year total shareholder returns above 20% suggest longer term holders...

LPL Financial Holdings (LPLA) is in focus after moving Commonwealth Financial Network’s 2,900 advisors from Advisor360° onto its ClientWorks platform, while also attracting multiple advisor teams managing hundreds of millions in client assets. See our latest analysis for LPL Financial Holdings. These advisor additions and the Commonwealth technology migration come as LPL’s share price sits at US$273.77, with a 1-day share price return of 2.98% but a year to date share price return down...

Wondering whether Berkshire Hathaway is attractively priced at around US$710,900 per share, or if the stock already reflects its strengths? This article breaks down what the current market value might be telling you. The share price is around US$710,900, with returns that declined 2.4% over the past week, were roughly flat over the past month at 0.1%, and declined 4.5% year to date and 6.1% over the past year, compared with gains of 41.3% over three years and 61.9% over five years. Recent...

Pharvaris recently announced that one oral presentation and seven flash talk/poster presentations on its oral HAE therapy deucrictibant were accepted for the European Academy of Allergy and Clinical Immunology Congress 2026, with materials to be shared via its investor website. The update also confirms that Pharvaris is preparing marketing authorization filings for deucrictibant and progressing multiple Phase 3 programs, positioning the drug as a potentially comprehensive treatment option...